📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Association of Long-Acting Injectable Antipsychotics and Oral Antipsychotics With Disease Relapse, Health Care Use, and Adverse Events Among People With Schizophrenia. (2022)

First Author: Wei Y

Attributed to: Data science and pharmacoepidemiology for outcome improvement in severe mental illness (DS-SMI) funded by UKRI FLF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1001/jamanetworkopen.2022.24163

PubMed Identifier: 35900760

Publication URI: http://europepmc.org/abstract/MED/35900760

Type: Journal Article/Review

Volume: 5

Parent Publication: JAMA network open

Issue: 7

ISSN: 2574-3805